ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California. Show more
12526 High Bluff Drive, San Diego, CA, 92130, United States
Start AI Chat
Market Cap
72.79M
52 Wk Range
$5.70 - $18.12
Previous Close
$6.51
Open
$6.54
Volume
31,962
Day Range
$6.53 - $6.95
Enterprise Value
111.5M
Cash
142.6M
Avg Qtr Burn
N/A
Insider Ownership
15.04%
Institutional Own.
49.22%
Qtr Updated
09/30/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|